Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
See Latest ArticlesGadolinium-Associated Nephrogenic Systemic Fibrosis
American Family Physician, 10/01/09
Schlaudecker JD et al. – Nephrogenic systemic fibrosis is a progressive, potentially fatal multiorgan system fibrosing disease related to exposure of patients with renal failure to the gadolinium–based contrast agents used in magnetic resonance imaging. Because of this relationship between nephrogenic systemic fibrosis and gadolinium–based contrast agents, the U.S. Food and Drug Administration currently warns against using gadolinium–based contrast agents in patients with a glomerular filtration rate less than 30 mL per minute per 1.73 m2, or any acute renal insufficiency related to the hepatorenal syndrome or perioperative liver transplantation. There have been reports of nephrogenic systemic fibrosis developing in patients not exposed to gadolinium–based contrast agents, but most patients have the triad of gadolinium exposure through contrast–enhanced magnetic resonance imaging, renal failure, and a proinflammatory state, such as recent surgery, endovascular injury, or sepsis.
Related Articles
Nephrogenic systemic fibrosis
Current Opinion in Rheumatology, 11/04/09
Relevance Score: 79%
Large Sample of Nephrogenic Systemic Fibrosis Cases From a Single Institution
Archives of Dermatology, 10/21/09
Relevance Score: 79%
UV-A1 Therapy for Nephrogenic Systemic Fibrosis
Archives of Dermatology, 10/21/09
Relevance Score: 79%
Advanced kidney disease, gadolinium and nephrogenic systemic fibrosis: the perfect storm
Current Opinion in Nephrology and Hypertension, 10/16/09
Relevance Score: 78%
Inflammatory process modulation in children with cystic fibrosis submitted to aerobic training
Archives of Medical Science, 11/03/09
Relevance Score: 65%
Today in Glomerular/Tubular Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
Serum levels of autoantibodies against C-reactive protein correlate with renal disease activity and response to therapy in lupus nephritis
Arthritis Research & Therapy, 12/16/09
Cdc42 Regulates Myocardin-Related Transcription Factor Nuclear Shuttling and [alpha]-Smooth Muscle Actin Promoter Activity during Renal Tubular Epithelial-Mesenchymal Transition
Nephron: Experimental Nephrology, 12/16/09
Management of lupus nephritis - current perspectives
Indian Journal of Rheumatology , 12/15/09
Article Search
Sponsor